retatrutide fda approval status november 2025 Status: July 2026 Update Retatrutide vs Tirzepatide: 28.7% vs

If the FDA removes semaglutide from the shortage list, compounding pharmacies ability to prepare these medications may change

(2022) Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Peptide Therapy in the Heart Disturbances, Myocardial Infarction, Heart Failure, Pulmonary Hypertension, Arrhythmias, and Thrombosis Presentation Biomedicines, 2022 Oct 25;10(11):2696

Retatrutide GI side effects tend to be more pronounced at equivalent efficacy levels, likely due to the additional glucagon-mediated GI motility effects layered on top of the GLP-1 gastric slowing

Professional Consultation Requirement This publication does not replace professional medical consultation, diagnosis, or treatment

The second is tirzepatide: Mounjaro is approved for diabetes and Zepbound for weight management again, same molecule, two names

Accurate low-dose measurement matters because the titration phase is specifically designed to minimize side effects like fatigue , nausea, and gastrointestinal discomfort that are more likely when starting doses are too high